Market Tracker

10/24 6:05pm ET

Galectin Therapeutics Inc (NASDAQ:GALT)

5.09
Data as of Oct 24
 +0.35 / +7.38%
Today’s Change
4.28
Today|||52-Week Range
19.11
-37.00%
Year-to-Date
No recent news for Galectin Therapeutics Inc.

Today’s Trading

Previous close4.74
Today’s open4.75
Day’s range4.75 - 5.09
Volume145,773
Average volume (3 months)658,171
Market cap$112.0M
Dividend yield--
Data as of 3:59pm ET, 10/24/2014

Growth & Valuation

Earnings growth (last year)-80.56%
Earnings growth (this year)-33.10%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book--

Competitors

 Today’s
change
Today’s
% change
ERBERBA Diagnostics Inc+0.09+3.20%
TROVTrovagene Inc-0.08-1.80%
LPDXLipoScience Inc-0.03-0.57%
QTNTQuotient Ltd+0.10+1.00%
Data as of 3:59pm ET, 10/24/2014

Financials

Next reporting dateNovember 13, 2014
EPS forecast (this quarter)-$0.27
Annual revenue (last year)$0.00
Annual profit (last year)-$21.1M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, Director &
Chief Medical Officer
Peter G. Traber
Chief Operating Officer &
Secretary
Harold H. Shlevin
Corporate headquarters
Norcross, Georgia

Forecasts